STOCK TITAN

C3is Financials

CISS
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

This page shows C3is (CISS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CISS FY2024

Cash generation, not reported earnings, drove the year, giving C3is room for deleveraging despite still-tight liquidity.

The clearest split is between accounting profit and cash conversion: operating cash flow was $25.0M while net income was -$2.7M, so the reported loss did not describe the cash engine of the business. Free cash flow of $23.4M also exceeded the year's financing outflow of -$19.7M, which helps explain why leverage eased without needing new external funding and why the balance sheet finished on firmer footing.

Top-line growth came with weaker operating efficiency: operating margin narrowed to 23.8% from 36.3%, so the added business did not scale cleanly through the cost base. Because operating income stayed positive even as net income turned negative, the earnings hit was recorded below day-to-day operations rather than in the operating core.

Balance-sheet repair was meaningful but not complete: debt-to-equity fell to 0.4x from 0.7x, and total liabilities dropped while cash rose. But the current ratio remained below 1.0x, so short-term claims still outweigh near-term resources even after a very cash-generative year.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 77 / 100
Financial Health Score 77/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of C3is's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
72

C3is has an operating margin of 3.9%, meaning the company retains $4 of operating profit per $100 of revenue. This strong profitability earns a score of 72/100, reflecting efficient cost management and pricing power. This is down from 23.8% the prior year.

Growth
65

C3is's revenue declined 17.8% year-over-year, from $42.3M to $34.8M. This contraction results in a growth score of 65/100.

Leverage
85

C3is carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
93

With a current ratio of 6.21, C3is holds $6.21 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 93/100.

Cash Flow
90

C3is converts 11.1% of revenue into free cash flow ($3.8M). This strong cash generation earns a score of 90/100.

Returns
57

C3is's ROE of 11.0% shows moderate profitability relative to equity, earning a score of 57/100. This is up from -3.9% the prior year.

Altman Z-Score Distress
1.12

C3is scores 1.12, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/7

C3is passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality
0.38x

For every $1 of reported earnings, C3is generates $0.38 in operating cash flow ($4.0M OCF vs $10.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage Safe
162.5x

C3is earns $162.5 in operating income for every $1 of interest expense ($1.4M vs $8K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$34.8M
YoY-17.8%

C3is generated $34.8M in revenue in fiscal year 2025. This represents a decrease of 17.8% from the prior year.

EBITDA
$7.9M
YoY-51.6%

C3is's EBITDA was $7.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 51.6% from the prior year.

Net Income
$10.5M
YoY+481.1%

C3is reported $10.5M in net income in fiscal year 2025. This represents an increase of 481.1% from the prior year.

EPS (Diluted)
$3.98

C3is earned $3.98 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
$3.8M
YoY-83.6%

C3is generated $3.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 83.6% from the prior year.

Cash & Debt
$617K
YoY-86.7%

C3is held $617K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
659,668

C3is had 659,668 shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
N/A
Operating Margin
3.9%
YoY-19.9pp

C3is's operating margin was 3.9% in fiscal year 2025, reflecting core business profitability. This is down 19.9 percentage points from the prior year.

Net Margin
30.1%
YoY+36.6pp

C3is's net profit margin was 30.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 36.6 percentage points from the prior year.

Return on Equity
11.0%
YoY+14.9pp

C3is's ROE was 11.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 14.9 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$162K
YoY-90.0%

C3is invested $162K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 90.0% from the prior year.

CISS Income Statement

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q4'22
Revenue N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A

CISS Balance Sheet

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q4'22
Total Assets $98.5M+9.3% $90.1M-10.3% $100.5M-26.9% $137.4M+43.9% $95.5M+139.5% $39.9M
Current Assets $20.8M+126.4% $9.2M-43.7% $16.3M-67.3% $50.0M+146.2% $20.3M+1884.4% $1.0M
Cash & Equivalents $617K-8.8% $676K-85.4% $4.6M-85.6% $32.3M+4548.0% $695K $0
Inventory $1.3M+14.9% $1.1M+29.2% $884K-20.3% $1.1M+61.0% $689K+316.1% $166K
Accounts Receivable N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A
Total Liabilities $3.4M-78.2% $15.5M-46.7% $29.1M-59.0% $71.1M+78.1% $39.9M+4035.6% $965K
Current Liabilities $3.4M-41.2% $5.7M-69.4% $18.7M-67.0% $56.6M+41.8% $39.9M+4035.6% $965K
Long-Term Debt N/A N/A N/A N/A N/A N/A
Total Equity $95.1M+27.5% $74.6M+4.5% $71.4M+7.6% $66.3M+19.4% $55.5M+42.8% $38.9M
Retained Earnings $4.5M+589.7% $650K+153.0% $257K+109.0% -$2.9M-134.3% $8.3M N/A

CISS Cash Flow Statement

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q4'22
Operating Cash Flow N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A

CISS Financial Ratios

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q4'22
Gross Margin N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A
Current Ratio 6.21+4.6 1.61+0.7 0.870.0 0.88+0.4 0.51-0.6 1.06
Debt-to-Equity 0.04-0.2 0.21-0.2 0.41-0.7 1.07+0.4 0.72+0.7 0.02
FCF Margin N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

C3is (CISS) reported $34.8M in total revenue for fiscal year 2025. This represents a -17.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

C3is (CISS) revenue declined by 17.8% year-over-year, from $42.3M to $34.8M in fiscal year 2025.

Yes, C3is (CISS) reported a net income of $10.5M in fiscal year 2025, with a net profit margin of 30.1%.

C3is (CISS) reported diluted earnings per share of $3.98 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

C3is (CISS) had EBITDA of $7.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

C3is (CISS) had an operating margin of 3.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

C3is (CISS) had a net profit margin of 30.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

C3is (CISS) has a return on equity of 11.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

C3is (CISS) generated $3.8M in free cash flow during fiscal year 2025. This represents a -83.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

C3is (CISS) generated $4.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

C3is (CISS) had $98.5M in total assets as of fiscal year 2025, including both current and long-term assets.

C3is (CISS) invested $162K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

C3is (CISS) had 659,668 shares outstanding as of fiscal year 2025.

C3is (CISS) had a current ratio of 6.21 as of fiscal year 2025, which is generally considered healthy.

C3is (CISS) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

C3is (CISS) had a return on assets of 10.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

C3is (CISS) has an Altman Z-Score of 1.12, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

C3is (CISS) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

C3is (CISS) has an earnings quality ratio of 0.38x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

C3is (CISS) has an interest coverage ratio of 162.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

C3is (CISS) scores 77 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top